ACLARION, INC. Accrued Liabilities, Current
ACLARION, INC. (ACON) had Accrued Liabilities, Current of $12.07 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-11-14
- 2023-09-30: Accrued Liabilities, Current $12.07K.
- 2023-06-30: Accrued Liabilities, Current $153.81K.
- 2022-12-31: Accrued Liabilities, Current $35.92K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2023-09-30 | $12.07K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $153.81K 10-Q · filed 2023-08-25 |
| 2022-12-31 | $35.92K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |